The BARIUM SULFATE SUSPENSION is a the manufacturer industrial component. Key specifications include administration: ORAL, features_provided: UNIT DOSE, primary_container_type: BAG, PLASTIC, secondary_container_type: CASE, pharmaceutical_vehicle_type: ANY ACCEPTABLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-474-8604, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| features_provided | UNIT DOSE |
| primary_container_type | BAG, PLASTIC |
| secondary_container_type | CASE |
| pharmaceutical_vehicle_type | ANY ACCEPTABLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 600.000 MILLILITERS |
| total_secondary_container_quantity | 1 |
| active_medicament_medicinal_strength | 13.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | BARIUM SULFATE SUSPENSION 600ML 1.38 LBS PER PLASTIC BAG 12S LBS |
| primary_container_quantity_per_secondary_container | 12 BAG, PLASTIC |
| NSN | 6505-01-474-8604 |
| FEATURES PROVIDED | UNIT DOSE |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION | ORAL |
| PHARMACEUTICAL VEHICLE TYPE | ANY ACCEPTABLE |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 13.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 12 BAG, PLASTIC |
| SECONDARY CONTAINER TYPE | CASE |
| TOTAL SECONDARY CONTAINER QUANTITY | 1 |
| PRIMARY CONTAINER CONTENT QUANTITY | 600.000 MILLILITERS |